Extracellular vesicles represent a rich source of novel biomarkers in the diagnosis and prognosis of disease. However, there is currently limited information elucidating the most efficient methods for obtaining high yields of pure exosomes, a subset of extracellular vesicles, from cell culture supernatant and complex biological fluids such as plasma. To this end, we comprehensively characterize a variety of exosome isolation protocols for their efficiency, yield and purity of isolated exosomes. Repeated ultracentrifugation steps can reduce the quality of exosome preparations leading to lower exosome yield. We show that concentration of cell culture conditioned media using ultrafiltration devices results in increased vesicle isolation when compared to traditional ultracentrifugation protocols. However, our data on using conditioned media isolated from the Non-SmallCell Lung Cancer (NSCLC) SK-MES-1 cell line demonstrates that the choice of concentrating device can greatly impact the yield of isolated exosomes. We find that centrifuge-based concentrating methods are more appropriate than pressure-driven concentrating devices and allow the rapid isolation of exosomes from both NSCLC cell culture conditioned media and complex biological fluids. In fact to date, no protocol detailing exosome isolation utilizing current commercial methods from both cells and patient samples has been described. Utilizing tunable resistive pulse sensing and protein analysis, we provide a comparative analysis of 4 exosome isolation techniques, indicating their efficacy and preparation purity. Our results demonstrate that current precipitation protocols for the isolation of exosomes from cell culture conditioned media and plasma provide the least pure preparations of exosomes, whereas size exclusion isolation is comparable to density gradient purification of exosomes. We have identified current shortcomings in common extracellular vesicle isolation methods and provide a potential standardized method that is effective, reproducible and can be utilized for various starting materials. We believe this method will have extensive application in the growing field of extracellular vesicle research.
of EVs (known as exosomes) is differential centrifugation, which typically consists of low-speed centrifugation to remove cells and large vesicles and high-speed ultracentrifugation to pellet exosomes (5) . Density gradients can then be utilized to remove contaminating impurities such as non-specific argonaute proteins (6) . Ultracentrifugation of large volumes of CCM can be cumbersome and results in sample loss depending on the skill of the operator. It has also been suggested in the literature that repeated ultracentrifugation steps can damage vesicles and reduce yields, thereby potentially impacting proteomic and RNA analysis of exosome content (7) . An alternative to ultracentrifugation is concentration of large volumes of CCM using ultrafiltration devices. Thus we have developed an optimized protocol for exosome isolation minimizing these issues.
In this study, we comprehensively detail tunable resistive pulse sensing (TRPS)-based assessments of particle size and concentration, in conjunction with protein analysis of purified exosomes in order to assess isolation efficacy. Using these analysis techniques, we address the impact of repeated ultracentrifugation steps on vesicle yield when compared to ultrafiltration of CCM. Our evaluation of particle yield and purity compares and contrasts 4 methods, including 2 commercial products that have not been assessed in the current literature: size exclusion chromatography (SEC) using qEV columns, and density gradient purification. Utilizing human plasma, we demonstrate that isolation techniques vary greatly in their ability to provide pure populations of exosomes. We find that OptiPrep TM gradient isolation provides the highest purification of exosomes from CCM, but is comparable to SEC when evaluating protein exosome markers. SEC is also shown to be exceptional in purifying exosomes from plasma and outperforms precipitation protocols that heavily co-isolate contaminating plasma proteins. This purity is essential for the comprehensive analysis of exosomes as potential biomarkers.
Materials and methods

Cell culture
The SK-MES-1 cell line was used to isolate exosomes. This cell line is an adherent human squamous Non-Small-Cell Lung Cancer (NSCLC) cell line. SK-MES-1 cells were obtained from ATCC, and authentication was carried out in-house using short tandem repeat (STR) profiling. Cells were maintained in Dulbecco's minimal essential medium (DMEM) supplemented with 10% foetal bovine serum, 100 U/mL penicillin and 100 mg/mL streptomycin and incubated at 378C in 5% CO 2 . Cells were grown to 70% confluency, washed 3 times with PBS and incubated for 24 hours in serum free media. CCM was collected after 24 hours, and cell cultures were trypsinized and analyzed for the presence of necrotic cells with trypan blue staining.
Plasma preparation
All plasma collection and preparation protocols were approved by the QIMR Berghofer Human Ethics Committee (P1499) and participants provided written, informed consent. All plasma used in this investigation was obtained from one individual. Twenty millilitres of blood was obtained from a healthy volunteer in EDTA-coated tubes and allowed to sit at room temperature for 30 minutes. Whole blood was then centrifuged at 1,200 g for 10 minutes at 48C to separate plasma. Plasma was transferred to a clean tube and centrifuged again at 1,800 g for 10 minutes at 48C before being aliquoted, snap frozen on dry ice and stored at (808C until use.
Ultracentrifugation CCM was harvested from SK-MES-1 cells and centrifuged using a Beckman Coulter Allegra † X-15R centrifuge at 300 g at 48C for 10 minutes to remove detached cells. Supernatant was collected and filtered through 0.22 mm filters (Merck Millipore) to remove contaminating apoptotic bodies, microvesicles and cell debris. Clarified CCM was then centrifuged in a Beckman Coulter Optima TM L-80XP Ultracentrifuge at 100,000 g avg at 48C for 90 minutes with a Type 50.2 Ti rotor (k-factor: 157.7) to pellet exosomes. The supernatant was carefully removed, and crude exosome-containing pellets were resuspended in 1 mL of ice-cold PBS and pooled. A second round of ultracentrifugation [100,000 g avg at 48C for 90 minutes with a Type 50.2 Ti rotor (k-factor: 157.7)] was carried out, and the resulting exosome pellet resuspended in 500 mL of PBS ( Supplementary Fig. 1 ).
Ultrafiltration
Clarified CCM was prepared as described above and concentrated to 500 mL using either pressure-driven or centrifugation-based concentrating protocols (Supplementary Fig. 2) . Briefly, 150 mL of CCM was concentrated to 5 mL in Stirred Cell Model 8200 with 100,000 kDa Biomax polyethersulfone or Ultracel regenerated cellulose membranes using nitrogen gas (10 psi). The 10 mL concentrate was transferred to an Amicon † Ultra-15 100,000 kDa device and concentrated further to 500 mL using an Allegra † X-15R centrifuge at 4,000 g at 48C. After use, membranes were washed with gentle shaking in either 30 mL 70% ethanol or 0.1 M NaOH for 5 minutes and rinsed 3 times in PBS for 5 minutes. Alternatively, 150 mL of CCM was concentrated to 500 mL with the Centricon Plus-70 Centrifugal Filter (Ultracel-PL Membrane, 100 kDa) device using an Allegra † X-15R centrifuge at 3,500 g at 48C. The concentrate was then recovered with a reverse spin at 1,000 g for 2 minutes. Centricon devices were washed with 30 mL 70% ethanol or 0.1 M NaOH by centrifugation at 3,500 g. Centricon devices were then rinsed by centrifugation at 3,500 g with 30 mL volumes of PBS ( Supplementary Fig. 2 ).
OptiPrep
TM density gradient purification Exosomes were purified using an OptiPrep TM density gradient. Briefly, a discontinuous iodixanol gradient was prepared by diluting a stock solution of OptiPrep TM (60% w/v) with 0.25 M sucrose/10 mM Tris, pH 7.5 to generate 40%, 20%, 10% and 5% w/v iodixanol solutions. With care, the discontinuous iodixanol gradient was generated by sequentially layering 3 mL each of 40, 20 and 10% (w/v) iodixanol solutions, followed by 2.5 mL of the 5% iodixanol solution in 14 )89 mm UltraClear TM Beckman Coulter centrifuge tubes. A 500 mL volume of CCM containing 6 )10 11 particles was overlaid on the discontinuous iodixanol gradient and centrifuged using a SW 40 Ti rotor for 16 hours at 100,000 g avg (k-factor: 277.5) at 48C. Fractions of 1 mL were collected from the top of the gradient and analyzed for particle concentration with TRPS. Positive fractions (6 and 7) were diluted to 20 mL in PBS and centrifuged at 100,000 g avg for 2 hours at 48C with a Type 50.2 Ti rotor (k-factor: 157.7). The resulting pellets were resuspended in 200 mL PBS.
ExoQuick
TM precipitation Exosome isolation from CCM ExoQuick TM precipitation was carried out according to manufacturer's instructions (System Biosciences). Briefly, 500 mL of clarified CCM was diluted to 5 mL in PBS and mixed with 1 mL of ExoQuick-TC TM solution by inverting the tube several times. The sample was incubated overnight at 48C then centrifuged twice at 1,500 g for 30 and 5 minutes, respectively, in order to remove the supernatant. The supernatant was discarded, and the pellet was resuspended in 200 mL of PBS.
Exosome isolation from human plasma Plasma was thawed on ice and centrifuged at 1,500 g for 10 minutes at 48C. The supernatant was removed, and large vesicles were removed with another centrifugation step at 10,000 g for 20 minutes at 48C. The supernatant was transferred to a new tube, and 2.5 mL of Thrombin (System Bioscience, TMEXO-1) was added to 250 mL of plasma and incubated for 5 minutes at room temperature to remove fibrinogen. The plasma was then centrifuged at 10,000 g for 5 minutes, and the supernatant was collected. The plasma was then incubated with ExoQuick TM for 60 minutes at 48C. The ExoQuick TM /plasma sample was then centrifuged twice at 1,500 g for 30 and 5 minutes, respectively, in order to remove the supernatant. The pellet was resuspended in 200 mL of PBS and filtered through an Ultrafree † 0.22 mm centrifugal filter device (Merck Millipore) to remove any large contaminating vesicles.
Exo-spin
TM precipitation Exosome isolation from CCM Exo-spin TM precipitation was carried out according to manufacturer's instructions (Cell Guidance Systems).
Briefly, 250 mL of precipitation buffer was mixed with 500 mL of clarified CCM and incubated overnight at 48C. The sample was then spun at 20,000 g for 30 minutes and the supernatant was discarded; the pellet was then resuspended in 100 mL of PBS. The sample was further purified using the provided columns, and exosomes were eluted in 200 mL of PBS.
Exosome isolation from human plasma For the isolation of exosomes from human plasma, 250 mL of plasma was thawed on ice and prepared by removing platelets and large vesicles by spinning at 1,500 g and 10,000 g for 10 and 20 minutes, respectively. Two-hundred microlitres of prepared plasma was then mixed with 100 mL of precipitation reagent and incubated at 48C for 5 minutes before pelleting exosomes at 20,000 g for 30 minutes. The supernatant was removed, and the exosome-containing pellet resuspended in 100 mL of PBS and purified on columns as before. The 200 mL exosome preparation was further filtered through an Ultrafree † 0.22 mm centrifugal filter device to remove any large contaminating vesicles.
Size exclusion purification
Five-hundred microlitres of clarified CCM, or 1 mL of processed plasma (centrifuged at 1,500 g and 10,000 g for 10 and 20 minutes, respectively) was overlaid on qEV size exclusion columns (Izon) followed by elution with PBS. Five-hundred-microlitre fractions were collected, and particle and protein concentrations determined with TRPS and the Bradford assay (Bio-Rad), respectively (Supplementary Fig. 3 ). High particle/low protein fractions from CCM were pooled and concentrated in Amicon † Ultra-4 10 kDa nominal molecular weight centrifugal filter units to a final volume of 200 mL. Fractions from plasma were pooled and filtered with an Ultrafree † 0.22 mm centrifugal filter device before being concentrated in an Amicon † Ultra-4 10 kDa device.
Tunable resistive pulse sensing
The concentration and size distribution of particles was analyzed with TRPS (qNano, Izon Science Ltd) using a NP100 nanopore at a 45 mm stretch. The concentration of particles was standardized using multi-pressure calibration with 70 nm carboxylated polystyrene beads at a concentration of 1.5 )10 11 particles/mL.
Electron microscopy
Exosomes were visualized using transmission electron microscopy (TEM) according to Thery et al. (5) . Briefly, 3 mL of exosome suspension was fixed in 50Á100 mL of 2% paraformaldehyde. Two microlitres of this mix was transferred onto each of 2 Formvar-carbon coated electron microscopy grids. Membranes were covered for 20 minutes. A 100 mL drop of PBS was placed on a sheet of parafilm and grids transferred with the sample membrane side facing down using clean forceps for 2 minutes. The grids were kept wet on the side of the membrane during all steps, but dry on the opposite side. The grids were transferred to a 50 mL drop of 1% glutaraldehyde for 5 minutes before transferring to a 100 mL drop of distilled water for 2 minutes. This was repeated 7 times for a total of 8 water washes. To contrast the samples, grids were transferred to a 50 mL drop of uranyl-oxalate solution, pH 7, for 5 minutes before transferring to a 50 mL drop of methyl-cellulose-UA (a mixture of 4% uranyl acetate and 2% methyl cellulose in a ratio of 100 mL/900 mL, respectively) for 10 minutes, placing the grids on a glass dish covered with parafilm on ice. The grids were removed with stainless steel loops and excess fluid blotted gently on Whatman no.1 filter paper. Grids were left to dry and stored in appropriate grid storage boxes. Grids were observed with JEM 1,011 transmission electron microscope at 80 kV.
Antibodies and reagents qEV columns were purchased from Izon and stored in PBS (0.1% sodium azide) at 48C. Exo-Spin TM and ExoQuick TM kits for blood and cell culture were purchased from Cell Guidance Systems and System Bioscience, respectively, and stored at 48C until use. OptiPrep TM was purchased from Sigma-Aldrich. The following antibodies were used for Western blotting: TSG101 (Santa Cruz, sc-6037), CD63 (Abcam, ab8219), Flotillin-1 (BD Transduction Laboratories, 610821), HSP70 (Transduction Laboratories, 610608), Calnexin (Cell Signaling Technology, 2679S) and Albumin (Cell Signaling Technology, 4929S). Horseradish peroxidase (HRP)-conjugated secondary antibodies were purchased from Thermo Scientific.
Western blot analysis
Western blots were performed as previously described (8, 9) . Briefly, exosome isolations were lysed in reducing sample buffer [0.25 M TrisÁHCl (pH 6.8), 40% glycerol, 8% SDS, 5% 2-mercaptoethanol and 0.04% bromophenol blue] or non-reducing sample buffer (without 2-mercaptoethanol) and boiled for 10 minutes at 958C. Proteins were resolved by SDS-PAGE (SDS-polyacrylamide gel electrophoresis), transferred to polyvinylidene fluoride membranes, blocked in 5% non-fat powdered milk in PBS-T (0.5% Tween-20) and probed with antibodies. All proteins were resolved under fully denaturing and reducing conditions, apart from CD63, which was resolved under non-reducing conditions. Protein bands were detected using X-ray film and enhanced chemiluminescence reagent (Amersham ECL Select).
Statistical methods
Statistical analyses were performed using Student's t-test and one-way analysis of variance. All experiments were performed as a minimum of 3 independent repeats. Differences with p-values less than 0.05 were considered significant (*p B0.05, **pB0.001, ***p B0.0001).
Results
SK-MES-1 cells secrete exosomes
The identification of particles as exosomes relies on various criteria. Exosomes range in size from 50 to 100 nm (8), they display a cup-shaped morphology by EM, and proteomic analysis reveals the presence of common proteins (9Á11). Figure 1a demonstrates the presence of canonical exosome proteins and the absence of the endoplasmic reticulum protein Calnexin from exosomes isolated using the ultrafiltration protocol ( Supplementary  Fig. 1 ). Furthermore, isolated particles exhibit expected morphology and size profiles consistent with pure exosome preparations (Fig. 1b and c) .
Centrifugal concentration provides optimal particle yield from CCM Currently, the main protein concentrating devices available are either pressure-driven (Stirred Cell) or centrifugationbased (Centricon). In order to investigate if there are differences in exosome yield between the 2 methods, we compared the Stirred Cell using a cellulose or biomax membrane with Centricon protein concentrators. Interestingly, using the Stirred Cell, both cellulose and biomax membranes recovered less particles than the Centricon device, which had an approximate 3-fold greater yield (Fig. 2a) . This was also seen when the abundance of the canonical exosome protein Flotillin-1 (9,10) was assessed (Fig. 2b) . When membranes were restored with sodium hydroxide, particle yield remained low in the Stirred Cell concentration workflow, with no impact on the yield from the Centricon (Fig. 2b) . However, when the membranes were washed thoroughly with ethanol and PBS, the yield from the Stirred Cell increased to levels comparable to the Centricon (Fig. 2c) . These data indicated that the Centricon method is superior in concentrating exosomes and that Stirred Cell membranes non-specifically bind a significant amount of exosomes.
Ultrafiltration is a faster alternative to ultracentrifugation To investigate the exact differences between ultracentrifugation and ultrafiltration on exosome yield and quality, we used a combination of particle analysis and protein assessment of positive markers. Particle tracking using TRPS showed that both ultracentrifugation and ultrafiltration isolated particles ranging in size from 50 to 250 nm (Fig. 3a) , with no difference observed in the percentage makeup of populations with defined size ranges (Fig. 3b) . Interestingly, ultrafiltration resulted in the highest recovery of particles B100 nm compared to ultracentrifugation (Fig. 3c) . Analysis of equal volumes of exosome preparations for HSP70 and Flotillin-1 was not sensitive enough to detect a higher ratio of exosomes between the 2 preparation methods; however, TSG101 expression was increased slightly in the ultrafiltration sample (Fig. 3d) . Both methods were therefore comparable in recovering exosomes, yet ultrafiltration was far more time efficient taking only 20 minutes to concentrate 150 mL of CCM compared to 2 rounds of ultracentrifugation for 90 minutes each. Repeated ultracentrifugation reduces particle yield and recovery Next, we examined if repeated ultracentrifugation rounds would reduce the quality and recovery of exosomes purified with a density gradient. Interestingly, ultracentrifugation consistently resulted in significantly higher particle concentrations in fractions 8Á10 (p B0.05) compared to exosomes prepared by ultrafiltration of CCM, suggesting that the different preparative methods altered particle characteristics (Fig. 4a ). This increase in particle concentration at higher densities for ultracentrifugation was accompanied with an increase in the membrane protein Flotillin-1, but not TSG101, potentially indicating ruptured membranes ( Supplementary  Fig. 4 ). Positive protein markers for exosomes overlap in fractions 6 and 7, and these fractions were pooled and ultracentrifuged at 100,000 g for 2 hours to pellet exosomes for further analysis. Both ultracentrifugation and ultrafiltration before OptiPrep TM did not alter the size distribution, or morphology of purified exosomes ( Fig. 4d and e) . However, ultrafiltration preparations would consistently produce significantly higher particle yields (Fig. 4b) , a result that was accompanied by a higher percentage recovery when total particles from fraction 6 and 7 were compared to total particles recovered (Fig. 4c) .
The choice of isolation method impacts on particle concentration and protein yield Exosomes were prepared from concentrated CCM of SK-MES-1 cells using 4 different isolation techniques.
With the recent increased interest in EV research, there have been numerous commercial products being developed for the rapid isolation of exosomes. We compared 3 commercially available products: ExoQuick TM , Exo-spin TM and Izon qEV columns with OptiPrep TM density gradient prepared exosomes. All 3 commercial products provided very similar size distribution profiles and morphology (Fig. 5a ), the only difference being the presence of particles !200 nm when compared to density gradient exosome preparations ( Fig. 5a and d) . ExoQuick TM and Exo-spin TM produced significantly higher yields of B100 nm particles compared to qEV and density gradient isolation techniques (Fig. 5b) . By contrast, when particles are expressed per mg of protein (a good indicator of particle purity (12)), ExoQuick TM is shown to perform poorly, suggesting the co-isolation of contaminating proteins (Fig. 5c ). Exo-spin TM performed significantly better compared to ExoQuick TM , but both qEV and density gradient are the superior isolation techniques (Fig. 5c) . Although there is a potential that precipitation protocols co-isolate a higher percentage of larger particles, we do not find this (Fig. 5d) , largely due to the preparation of CCM with a 0.22 mm filtration step. The absence of larger particles is further validated with a larger nanopore (Supplementary Fig. 5 ). The increased ratio of particles per mg of protein seen with qEV columns compared to density gradient purification is most likely due to the loss of particles associated with density gradient purification (Fig. 4a) . When selecting purely on size this loss is avoided, providing higher recovery of particles B100 nm in size. Density gradient and qEV samples are enriched for exosome markers In order to validate the use of particles per mg of protein ratio as a measure of isolation efficacy, we assessed specific protein content by Western blot. We analyzed exosome markers using 10 mg of protein from each isolation method and found elevated levels of exosomal markers HSP70, Flotillin-1 and TSG101 in qEV and density gradient lysates compared to ExoQuick TM and Exo-spin TM (Fig. 5e ). This further supports the idea that current precipitation techniques perform poorly in providing pure exosome preparations. Exo-spin TM yielded higher levels of exosome markers compared to ExoQuick TM , indicating the importance of a post-precipitation purification step. In conclusion, both ExoQuick TM and Exo-spin TM have significantly more non-exosomal protein contamination as evidenced by the particle/protein ratio combined with increased exosome marker expression in qEV and density gradient isolations (Fig. 5) .
SEC outperforms precipitation of exosomes isolated from human plasma
In order to assess the utility of these techniques on the isolation of exosomes from human bodily fluids, we isolated exosomes from normal human plasma using ExoQuick TM , Exo-spin TM and qEV columns. Density gradient purification has been shown to provide the most pure exosome preparation from plasma (13); however, due to the often-limited sample availability of plasma, we decided to assess techniques that would not require more than 1 mL of plasma. All 3 methods isolate particles with a size range equivalent to exosomes (Fig. 6a) , but recovery of particles from plasma is dependent on the isolation process (Fig. 6b ). At a low purity level, both precipitation protocols recover the majority of particles in relation to unprocessed plasma (Fig. 6b) . The SEC method using qEV columns provided the lowest exosome recovery rate (Fig. 6b) , but with the highest purity, based on the selective inclusion of eluted fractions. Similar to the isolation of exosomes from CCM, when the concentration of particles is expressed relative to protein concentration, ExoQuick TM performs very poorly (Fig. 6c) . Exo-spin TM provides a significantly higher purification compared to ExoQuick TM , but column purification alone provides the highest degree of purification (Fig. 6c) . This is supported by EM, and Western blot analysis of 50 mg of protein. EM images indicate a high degree of contamination in exosome isolations (Fig. 6a) , and Flotillin-1 was only detectable in the samples isolated with qEV technique (Fig. 6d) . This was further accompanied with a high degree of albumin contamination in the ExoQuick TM and Exo-spin TM that was not present in the qEV isolation (Fig. 6d) .
Discussion
EVs, including exosomes, are present in human biofluids such as plasma (1, 14, 15) . As such, they can potentially serve as a source of novel biomarkers in the diagnosis and prognosis of diseases such as cancer or infectious diseases. As yet, the scientific community has not yet fully taken advantage of EVs which may be due to a lack of a standardized purification method. Although differential centrifugation coupled to ultracentrifugation has been the most widely adopted of methods, the impacts of repeated ultracentrifugation steps on the recovery of exosome yields has not been fully assessed. Ultracentrifugation is also not always applicable to clinical samples due to the volume of required starting material and the low throughput of this method. Moreover, standardization of purification protocols from CCM and biological fluids is necessary as disparate techniques impact on downstream protein and RNA profiling (16) . To this end, new rapid isolation protocols were assessed for yield and purity in order to standardize and optimize exosome purification protocols from CCM and human plasma. Ultracentrifugation is the most widely used exosome purification protocol and has long been considered the gold standard for isolation of relatively homogenous size populations of exosomes (3, 17, 18) . However, this process is lengthy and often results in variable recovery rates due to differences among researchers using different rotor types (19) . Further, repeated ultracentrifugation steps may damage isolated vesicles, reducing their quality. We show that ultrafiltration is capable of isolating exosomes (Fig. 1) , and provides a higher particle yield compared to ultracentrifugation, thereby increasing exosome yield and isolation efficiency (Fig. 3) . The increased yield of particle concentration is also coupled to a shorter processing time, thereby increasing the efficiency of sample throughput. This supports previous research that indicates that concentration methods are more suitable for producing clinical grade exosomes in time efficiency and quality compared to the classical ultracentrifugation protocol (7) .
Ultrafiltration is a powerful tool in optimizing exosome isolations, yet it was unclear what concentrating methods are most appropriate for exosome isolations. Particle yield can be dramatically low in pressure-driven concentrating devices compared to centrifuge concentrating devices (Fig. 2) . Non-specific absorption to both cellulose and biomax membranes of the Stirred Cell causes this reduction.
However, once the membrane has been sufficiently ''blocked'' with exosome particles, the yield from CCM is comparable to the Centricon. This is supported with washing the membranes with ethanol or sodium hydroxide. When the membrane was fully restored with sodium hydroxide, particle yield would remain low; however, an ethanol wash resulted in maximized particle yield (Fig. 2) . This is most likely due to the large surface area (28.7 cm 2 ), and contact time with the membrane of the Stirred Cell. This loss of particles does not occur with Centricons due to the lower surface area of the membrane (19 cm 2 ), and a reverse centrifugation step allowing particles to be spun off the membrane. Given this, when working with volumes of 50Á200 mL of conditioned media, a centrifugebased concentrator is the most appropriate device. Some applications may require the use of larger volumes of CCM. We found that pressure-driven concentrating is more appropriate with volumes in excess of 400 mL due to the higher flow rate, and that exosome loss is only observed with the first 50Á100 mL of CCM.
Previous studies on comparing exosome isolation techniques have been carried out (6, 13, 20) , but there is limited information regarding recent precipitation-based isolation techniques. In addition to updating the analysis of these techniques, we compared preparation efficacy utilizing the NSCLC cell line SK-MES-1 for yield. Density gradient purification is a technique repeatedly shown to provide the highest degree of purity (6, 12, 13) . Interestingly, separation of particles with a density gradient revealed a large abundance of particles in lower density fractions, particularly fractions 3Á5 (Fig. 4) , demonstrating a heterogeneity of particles among exosome preparations. This heterogeneity has been described by others (21) , showing the presence of particles with different structural and biochemical features due to different mechanisms of biogenesis. Importantly, it should be recognized that ExoQuick TM , Exo-spin TM and qEV are unable to resolve this particle heterogeneity, leading to the isolation of nonexosomal particles.
For the determination of an isolation method that delivers the purest exosome isolation, the combination of both particle and protein concentration analysis is required as either alone is insufficient to determine the overall performance of an isolation technique. All methods (ExoQuick TM , Exo-spin TM , qEV and density gradient) were shown to isolate exosomes from CCM as indicated by EM, size profiling using TRPS and Western blot analysis. The importance of using both particle and protein concentration is indicated as precipitation protocols produced the highest yield of particles, yet had the lowest ratio of particles to protein, potentially due to co-isolation of contaminants ( Fig. 5b and c) . It is a possibility that high particle low protein measurements could be attained if exosomes were damaged during the isolation protocol and lost some protein cargo. However, given that qEV columns provided the highest number of particles per mg of protein, it is unlikely this is happening to any large degree due to the relatively ''gentle'' nature of this isolation method. To further support this, Western blot analysis demonstrated that qEV and density gradient fractions were enriched for exosomal markers, and to a lesser degree Exo-spin TM , whereas ExoQuick TM -based isolations demonstrated lower enrichment of exosomal markers (Fig. 5e) . A key message from these data is that protein concentration is not a good measure of exosome yield, and though common organelle markers such as Calnexin are used to assess purity of exosomes they are insufficient to indicate that isolation techniques are devoid of contaminates.
The utility of all exosome isolation methods are dependent on their performance when applied to human clinical samples, particularly when the focus of exosomes as novel biomarkers is being considered. Modern precipitation protocols have been purported as alternative methods to ultracentrifugation because they require very little starting sample from human biofluids combined with high-throughput options. Isolating exosomes from plasma is further complicated due to viscosity and density issues (5, 22) , thereby limiting the purity obtained from ultracentrifugation protocols. Recently, a single-step SEC isolation of exosomes from human plasma has been described (23) . Using a similar approach, we find similar results in the efficiency of qEV SEC columns to separate exosome vesicles from contaminating plasma proteins. SEC, however, does not concentrate samples and therefore requires a second step. Instead of pelleting exosomes with an ultracentrifugation step, we used protein concentrating devices to rapidly concentrate exosomal fractions. This provides an efficient means of isolating and concentrating exosomes from human plasma, while avoiding ultracentrifugation (Fig. 6) . SEC purification using qEV columns significantly outperformed both precipitation protocols when the particle protein ratio was considered (Fig. 6) . This is also supported by analysis of Flotillin-1. Flotillin-1 could not be detected in both precipitation protocols but was present in the SEC isolation samples. Furthermore, the purity of exosome isolations is important and can be classified through a number of methods, including the presence of contaminating extracellular proteins (24) . Though no contaminating extracellular protein is shown in the in vitro precipitation isolations, Fig. 6d demonstrates the high abundance of contaminating albumin with the precipitation methods from human plasma compared to qEV columns. This furthers the assumption that precipitation protocols are prone to heavy contamination with plasma proteins and are therefore limited in their utility for proteomic analysis of exosomes from human plasma.
Isolation techniques that have been well characterized are crucial for the analysis of exosomes as biomarkers. In conclusion, we have investigated the influence of repeated ultracentrifugation of CCM on the integrity of exosomes and found that it is detrimental to achieve the highest recovery of particles. Modern ultrafiltration devices provide a more rapid and overall higher yield of exosomes when compared to ultracentrifugation. The steps of differential centrifugation also have an impact on the input before density gradient purification (19, 25) , a problem that may bias subsequent analysis that ultrafiltration avoids. Therefore, adoption of concentrating protocols will provide improved analysis of exosomes. We show that ultrafiltration coupled with SEC is a method that provides particle purity comparable to density gradient purification and is applicable to isolating a high yield of exosomes from CCM and human plasma in an efficient time frame. These data should inform the community in developing optimal techniques for exosome extraction and research.
